Related Experiment Video
Updated: Jan 22, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Functional analyses of microRNA-326 in breast cancer development
Ye Du1, Lishengnan Shen1, Wei Zhang2
1Department of Breast Surgery, The First Hospital of Jilin University, Changchun 130021, Jilin, P.R. China.
Abstract:
MicroRNA-326 (miR-326) was reported to be dysregulated and involved in the progression of multiple cancers. However, the clinical significance, biological role and underlying mechanism of miR-326 in the carcinogenesis of breast cancer are still unclear. In the present study, we showed that miR-326 was down-regulated in human breast cancer tissues and cell lines. Our results also revealed that miR-326 overexpression significantly suppressed breast cancer cell proliferation, migration and invasion, and induced cell cycle arrest at G1/G0 phase. Furthermore, Sex determining region Y-box (SOX) protein 12 (SOX12), a known oncogene, was identified as a direct target of miR-326 by luciferase reporter assay. Moreover, miR-326 expression was inversely correlated with SOX12 mRNA expression levels in human breast cancer specimens. Overexpression of SOX12 partially rescued the inhibitory effect on cell proliferation, migration and invasion in breast cancer cells caused by miR-326 overexpression. These findings suggested that miR-326 might play a suppressive role in breast cancer, at least in part, by targeting SOX12, rendering miR-326 a promising therapeutic target for breast cancer.
Insights
MicroRNA-326 (miR-326) is downregulated in breast cancer, suppressing tumor growth and invasion by targeting the oncogene SOX12. This suggests miR-326 is a potential therapeutic target for breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-326 (miR-326) is implicated in various cancers, but its role in breast cancer remains unclear.
- Understanding miR-326's function is crucial for developing new breast cancer therapies.
Purpose of the Study:
- To investigate the clinical significance and biological role of miR-326 in breast cancer.
- To elucidate the underlying molecular mechanism of miR-326 in breast cancer progression.
Main Methods:
- Quantitative analysis of miR-326 expression in breast cancer tissues and cell lines.
- Functional assays (proliferation, migration, invasion, cell cycle) to assess miR-326's effects.
- Luciferase reporter assay to identify direct targets of miR-326.
- Correlation analysis between miR-326 and SOX12 expression in patient samples.
Main Results:
- miR-326 expression was significantly downregulated in human breast cancer tissues and cell lines.
- Overexpression of miR-326 inhibited breast cancer cell proliferation, migration, and invasion, inducing G1/G0 cell cycle arrest.
- Sex determining region Y-box 12 (SOX12) was identified as a direct target of miR-326.
- miR-326 expression inversely correlated with SOX12 mRNA levels in breast cancer specimens.
- SOX12 overexpression partially rescued the tumor-suppressive effects of miR-326.
Conclusions:
- miR-326 acts as a tumor suppressor in breast cancer, partly by targeting the oncogene SOX12.
- miR-326 represents a promising therapeutic target for breast cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Fruit Development, Structure, and Function
Sustainable Development
Functional Groups
Cancer

